Isabelle Quadrio

2.4k total citations
60 papers, 1.2k citations indexed

About

Isabelle Quadrio is a scholar working on Molecular Biology, Neurology and Physiology. According to data from OpenAlex, Isabelle Quadrio has authored 60 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 23 papers in Neurology and 18 papers in Physiology. Recurrent topics in Isabelle Quadrio's work include Prion Diseases and Protein Misfolding (19 papers), Alzheimer's disease research and treatments (18 papers) and Neurological diseases and metabolism (14 papers). Isabelle Quadrio is often cited by papers focused on Prion Diseases and Protein Misfolding (19 papers), Alzheimer's disease research and treatments (18 papers) and Neurological diseases and metabolism (14 papers). Isabelle Quadrio collaborates with scholars based in France, Belgium and United States. Isabelle Quadrio's co-authors include Armand Perret‐Liaudet, Pierre Krolak‐Salmon, Anthony Fourier, Yannick Tholance, Claire Roubaud‐Baudron, Françis Mégraud, Nathalie Salles, Aline Dorey, Alain Vighetto and Gábor G. Kovács and has published in prestigious journals such as Neurology, Chemical Communications and Journal of Virology.

In The Last Decade

Isabelle Quadrio

52 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabelle Quadrio France 20 517 472 331 315 268 60 1.2k
Randy Woltjer United States 23 369 0.7× 427 0.9× 283 0.9× 224 0.7× 233 0.9× 62 1.3k
John Kauwe United States 24 659 1.3× 834 1.8× 313 0.9× 289 0.9× 261 1.0× 53 1.7k
Susana Boluda Spain 18 407 0.8× 443 0.9× 329 1.0× 119 0.4× 246 0.9× 49 1.3k
Sarah Jesse Germany 18 363 0.7× 280 0.6× 490 1.5× 100 0.3× 195 0.7× 43 1.1k
R. Surtees United Kingdom 24 994 1.9× 425 0.9× 417 1.3× 168 0.5× 165 0.6× 45 2.2k
Belén Pérez‐Dueñas Spain 28 847 1.6× 349 0.7× 408 1.2× 110 0.3× 97 0.4× 109 2.0k
J J Hauw France 20 615 1.2× 505 1.1× 393 1.2× 193 0.6× 318 1.2× 39 1.3k
Tadanori Hamano Japan 20 426 0.8× 543 1.2× 356 1.1× 53 0.2× 145 0.5× 91 1.3k
Alessandro Salviati Italy 16 351 0.7× 622 1.3× 230 0.7× 411 1.3× 235 0.9× 45 1.3k
Thomas Opladen Germany 24 782 1.5× 191 0.4× 199 0.6× 134 0.4× 86 0.3× 84 1.9k

Countries citing papers authored by Isabelle Quadrio

Since Specialization
Citations

This map shows the geographic impact of Isabelle Quadrio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Quadrio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Quadrio more than expected).

Fields of papers citing papers by Isabelle Quadrio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Quadrio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Quadrio. The network helps show where Isabelle Quadrio may publish in the future.

Co-authorship network of co-authors of Isabelle Quadrio

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Quadrio. A scholar is included among the top collaborators of Isabelle Quadrio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Quadrio. Isabelle Quadrio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Violle, Nicolas, et al.. (2025). Functional discrimination of CSF from Alzheimer’s patients in a brain on chip platform. Scientific Reports. 15(1). 29738–29738. 1 indexed citations
2.
Delorme, Cécile, Antoine Pégat, Jean‐Philippe Brandel, et al.. (2025). Demyelinating neuropathy as the initial presentation of familial E200K Creutzfeldt–Jakob disease in two patients. Annals of Clinical and Translational Neurology. 12(3). 653–658.
3.
Verdurand, Mathieu, Sophie Dautricourt, Virginie Desestret, et al.. (2025). Toward alpha‐synuclein seed amplification assay in clinical practice. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 17(1). e70066–e70066. 5 indexed citations
4.
Schraen‐Maschke, Susanna, Isabelle Quadrio, Olivier Bousiges, et al.. (2024). A French multicenter analytical evaluation of the automated Lumipulse G sNfL blood assay (Fujirebio®) and its comparison to four other immunoassays for serum neurofilament light chain assessment in clinical settings. Clinica Chimica Acta. 565. 120007–120007. 2 indexed citations
5.
6.
Verdurand, Mathieu, et al.. (2022). Charge detection mass spectrometry on human-amplified fibrils from different synucleinopathies. Chemical Communications. 58(51). 7192–7195. 4 indexed citations
7.
Fourier, Anthony & Isabelle Quadrio. (2022). Proteinopathies associated to repeat expansion disorders. Journal of Neural Transmission. 129(2). 173–185. 4 indexed citations
8.
Fourier, Anthony, et al.. (2020). A combination of total tau and neurofilaments discriminates between neurodegenerative and primary psychiatric disorders. European Journal of Neurology. 27(7). 1164–1169. 12 indexed citations
9.
10.
Verdurand, Mathieu, Sophie Lancelot, Waël Zeinyeh, et al.. (2018). Amyloid-Beta Radiotracer [18F]BF-227 Does Not Bind to Cytoplasmic Glial Inclusions of Postmortem Multiple System Atrophy Brain Tissue. Contrast Media & Molecular Imaging. 2018. 1–7. 16 indexed citations
11.
Chapuis, Jérôme, Mohammed Moudjou, Fabienne Reine, et al.. (2016). Emergence of two prion subtypes in ovine PrP transgenic mice infected with human MM2-cortical Creutzfeldt-Jakob disease prions. Acta Neuropathologica Communications. 4(1). 10–10. 27 indexed citations
12.
Dorey, Aline, Armand Perret‐Liaudet, Yannick Tholance, Anthony Fourier, & Isabelle Quadrio. (2015). Cerebrospinal Fluid Aβ40 Improves the Interpretation of Aβ42 Concentration for Diagnosing Alzheimer’s Disease. Frontiers in Neurology. 6. 247–247. 51 indexed citations
13.
Leitão, Maria João, Inês Baldeiras, Sanna‐Kaisa Herukka, et al.. (2015). Chasing the Effects of Pre-Analytical Confounders – A Multicenter Study on CSF-AD Biomarkers. Frontiers in Neurology. 6. 153–153. 39 indexed citations
14.
Fourier, Anthony, Erik Portelius, Henrik Zetterberg, et al.. (2015). Pre-analytical and analytical factors influencing Alzheimer's disease cerebrospinal fluid biomarker variability. Clinica Chimica Acta. 449. 9–15. 58 indexed citations
15.
Quadrio, Isabelle, Armand Perret‐Liaudet, & Gábor G. Kovács. (2011). Molecular diagnosis of human prion disease. Expert Opinion on Medical Diagnostics. 5(4). 291–306. 7 indexed citations
16.
Dorey, Aline, Nathalie Streichenberger, G. Viennet, et al.. (2011). Rapid screening and confirmatory methods for biochemical diagnosis of human prion disease. Journal of Virological Methods. 175(2). 216–223. 12 indexed citations
17.
Gabelle, Audrey, Stéphane Roche, Christian Gény, et al.. (2010). Correlations between soluble α/β forms of amyloid precursor protein and Aβ38, 40, and 42 in human cerebrospinal fluid. Brain Research. 1357. 175–183. 54 indexed citations
18.
Rogez‐Kreuz, Christine, et al.. (2009). Inactivation of Animal and Human Prions by Hydrogen Peroxide Gas Plasma Sterilization. Infection Control and Hospital Epidemiology. 30(8). 769–777. 42 indexed citations
19.
Quadrio, Isabelle, Nathalie Streichenberger, Pierre Krolak‐Salmon, et al.. (2009). Rapid diagnosis of human prion disease using streptomycin with tonsil and brain tissues. Laboratory Investigation. 89(4). 406–413. 7 indexed citations
20.
Zorzi, Willy, Isabelle Quadrio, Armand Perret‐Liaudet, et al.. (2009). Creutzfeldt-Jakob, Parkinson, Lewy Body Dementia and Alzheimer Diseases: From Diagnosis to Therapy. Central Nervous System Agents in Medicinal Chemistry. 9(1). 2–11. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Randy Woltjer Breakdown of academic impact, for papers by John Kauwe Breakdown of academic impact, for papers by Susana Boluda Breakdown of academic impact, for papers by Sarah Jesse Breakdown of academic impact, for papers by R. Surtees Breakdown of academic impact, for papers by Belén Pérez‐Dueñas Breakdown of academic impact, for papers by J J Hauw Breakdown of academic impact, for papers by Tadanori Hamano Breakdown of academic impact, for papers by Alessandro Salviati Breakdown of academic impact, for papers by Thomas Opladen
Rankless by CCL
2026